WO2001058861A1 - Process for making and using isocyanide resins - Google Patents

Process for making and using isocyanide resins Download PDF

Info

Publication number
WO2001058861A1
WO2001058861A1 PCT/US2001/004219 US0104219W WO0158861A1 WO 2001058861 A1 WO2001058861 A1 WO 2001058861A1 US 0104219 W US0104219 W US 0104219W WO 0158861 A1 WO0158861 A1 WO 0158861A1
Authority
WO
WIPO (PCT)
Prior art keywords
resin
isocyanide
alkyl
carried out
resins
Prior art date
Application number
PCT/US2001/004219
Other languages
French (fr)
Inventor
Jian Chen
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to AU2001234975A priority Critical patent/AU2001234975A1/en
Publication of WO2001058861A1 publication Critical patent/WO2001058861A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/10Isocyanides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48Polymers modified by chemical after-treatment
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0622Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • C08G73/0638Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with at least three nitrogen atoms in the ring

Definitions

  • the subject invention involves a process for making isocyanide resins from amino acid resins, and uses thereof.
  • Multi-component condensation reactions such as the Passerini and Ugi reactions
  • Many pharmaceutically important scaffolds can be constructed using these reactions.
  • isocyanide reagents Previous accounts of studies recently addressed this problem by immobilizing isocyanide functionality to solid supports; see (a) Zhang et al, Tetrahedron Lett., Vol. 37 (1996), pp. 751-754; (b) Short et al.,
  • the subject invention involves a process for making isocyanide resin from amino acid resin comprising the following steps: (a) formylation of an amino acid resin of structure 1 to produce resin 2:
  • R is selected from the group consisting of hydrogen, alkyl, aryl, and heterocyclyl
  • alkyl means a hydrocarbon chain which is branched, linear or cyclic, saturated or unsaturated (but not aromatic), substituted or unsubstituted.
  • alkyl may be used alone or as part of another word where it may be shortened to "alk” (e.g., in alkoxy, alkylacyl).
  • Preferred linear alkyl have from one to about twenty carbon atoms, more preferably from one to about ten carbon atoms, more preferably still from one to about six carbon atoms, still more preferably from one to about four carbon atoms; most preferred are methyl or ethyl.
  • Preferred cyclic and branched alkyl have from three to about twenty carbon atoms, more preferably from three to about ten carbon atoms, more preferably still from three to about seven carbon atoms, still more preferably from three to about five carbon atoms.
  • Preferred cyclic alkyl have one hydrocarbon ring, but may have two, three, or more, fused or spirocycle hydrocarbon rings.
  • Preferred alkyl are unsaturated with from one to about three double or triple bonds, preferably double bonds; more preferably they are mono-unsaturated with one double bond. Still more preferred alkyl are saturated. Saturated alkyl are referred to herein as "alkanyl".
  • alkyl unsaturated only with one or more double bonds (no triple bonds) are referred to herein as "alkenyl”.
  • Preferred substituents of alkyl include halo, alkyl, aryl, heterocyclyl, hydroxy, alkoxy, aryloxy, thio, alkylthio, arylthio, amino, alkylamino, arylamino, amide, alkylamide, arylamide, formyl, alkylacyl, arylacyl, carboxy and its alkyl and aryl esters and amides, nitro, and cyano. Also, unsubstituted alkyl are preferred.
  • heteroatom means a nitrogen, oxygen, or sulfur atom.
  • alkylene means an alkyl which connects two other moieties, “heteroalkylene” means an alkylene having one or more heteroatoms in the connecting chain.
  • aryl means an aromatic hydrocarbon ring (or fused rings) which is substituted or unsubstituted.
  • aryl may be used alone or as part of another word (e.g., in aryloxy, arylacyl).
  • Preferred aryl have from six to about fourteen, preferably to about ten, carbon atoms in the aromatic ring(s), and a total of from about six to about twenty, preferably to about twelve, carbon atoms.
  • Preferred aryl is phenyl or naphthyl; most preferred is phenyl.
  • Preferred substituents of aryl include halo, alkyl, aryl, heterocyclyl, hydroxy, alkoxy, aryloxy, thio, alkylthio, arylthio, amino, alkylamino, arylamino, amide, alkylamide, arylamide, formyl, alkylacyl, arylacyl, carboxy and its alkyl and aryl esters and amides, nitro, and cyano. Also, unsubstituted aryl are preferred.
  • heterocyclyl means a saturated, unsaturated or aromatic cyclic hydrocarbon ring (or fused rings) with one or more heteroatoms in the hydrocarbon ring(s).
  • Preferred heterocyclyls have from one to about six heteroatoms in the ring(s), more preferably one or two or three heteroatoms in the ring(s).
  • Preferred heterocyclyls have from three to about fourteen, preferably to about ten, carbon plus heteroatoms in the ring(s), more preferably from three to about seven, more preferably still five or six, carbon plus heteroatoms in the rings(s); and a total of from three to about twenty carbon plus heteroatoms, more preferably from three to about ten, more preferably still five or six, carbon plus heteroatoms.
  • Preferred heterocyclyls have one ring, but may have two, three, or more, fused or spirocycle rings. More preferred heterocyclyl rings include those which are one ring with 5 or 6 carbon plus heteroatoms in the ring with no more than three ring heteroatoms, no more than two of which are O and S.
  • Such preferred 5- or 6-ring atom heterocyclyls are preferably saturated, unsaturated with one or two double bonds, or aromatic.
  • Such preferred 5- or 6-ring atom heterocyclyls are preferably a single ring; or fused with a 3- to 6-ring atom hydrocarbon ring which is saturated, unsaturated with one double bond, or aromatic (phenyl); or fused with another such 5- or 6-ring atom heterocyclic ring.
  • Heterocyclyls are unsubstituted or substituted. Preferred heterocyclyl substituents are the same as for alkyl.
  • heteroaryl means an aromatic heterocyclyl.
  • the first step of the subject invention process for making isocyanide resin is the formylation of amino acid resin 1 as follows:
  • the formylating reagent is preferably formic acid in the presence of diisopropyl carbodiimide.
  • the reaction is preferably carried out at a temperature of from about 0°C to about room temperature over a period of from about 1-4 hours.
  • Formylated resin 2 is dehydrated to isocyanide resin 3 using POCl ⁇ /diisopropylethylamine
  • DIPEA DIPEA
  • the dehydration reaction is preferably carried out at a temperature of from about 0°C to about room temperature over a period of from about 3-8 hours.
  • the above process is generally quantitative and produces resins of light yellow color that are stable for months when stored refrigerated.
  • Side chain protections typically used in the above processes such as Boc, t-Bu, O-t-Bu, Tos, O-Bzl, and 2,2,4,6,7-pentamethyl-dihydrobenzofuran- sulfonyl (Pbf) are preserved during this conversion.
  • the amino acid resin starting material is preferably a commercially-available ⁇ -amino acid resin.
  • Non-limiting examples of commercially-available ⁇ -amino acid resins useful as starting materials for the subject process include Fmoc-Phe-Wang, Fmoc-Lys(Boc)-Wang, Fmoc-Tyr(tBu)- Wang, Fmoc-Asp(OtBu)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Arg(Pbf)-Merrifield, Boc-Phe- Merrifield, Boc-Ser(OBzl)-Merrifield, Boc-Met-Merrifield, Boc-His(Tos)-Merrifield, Boc- Thr(OBzl)-Merrifield, Boc-Ala-Merrifield resins.
  • R is selected from hydrogen, alkyl, aryl, and heterocyclyl.
  • Preferred R is unsubstituted or substituted alkyl, preferably having from 1 to about 8 carbon atoms, more preferably from 1 to about 4 carbon atoms.
  • Preferred substituents of such alkyl include unsubstituted and substituted hydroxy, amino, thio, and phenyl.
  • a deprotected amino acid resin ester is swelled in anhydrous dichloromethane (DCM). Under the ice cooling, formic acid (8 eq) is added, followed by diisopropylcarbodiimide (DIC) (8 eq). The suspension is stirred at 0°C for half hour, then for 1 1/2 h at room temperature. The resin is washed and dried to a constant weight. The formylated amino acid resin is suspended in anhydrous CH2CI2. Under ice cooling and Argon protection, diisopropylethylamine (DIPEA) (15 eq) is cannulated, followed by POCI3 (5eq).
  • DIPEA diisopropylethylamine
  • the isocyanide resins made according to the subject invention process are useful for making a variety of compounds which use an isocyanide reactant. Such compounds include, but are not limited to, dipeptides, ⁇ -lactams, iminohydantoins, benzodiazepins, diketopiperazines.
  • the isocyanide resins made according to the subject invention process are particularly useful for making combinatorial libraries of the above compounds.
  • the subject resins are reliable isocyanide resources for Ugi 3CC reactions.
  • the reactions on these resins tolerate a wide range of amines and aldehydes.
  • Aliphatic aldehydes tend to provide products with higher yield and purity.
  • Aromatic aldehydes which are problematic in other Ugi condensation reactions, perform satisfactorily with these resins.
  • Non-limiting examples of compounds made according to the above scheme and example using corresponding aldehydes, secondary amines, and isocyanide resins include 3a - 3i:

Abstract

A process for making isocyanide resin from amino acid resin comprising the steps: (a) formylation of an amino acid resin, and (b) dehydration of the formylated resin.

Description

PROCESS FOR MAKING AND USING ISOCYANIDE RESINS
FIELD OF THE INVENTION The subject invention involves a process for making isocyanide resins from amino acid resins, and uses thereof.
CROSS REFERENCE This application claims priority under Title 35, United States Code 119(e) from Provisional Application Serial No. 60/181,266, filed February 9, 2000. BACKGROUND
Multi-component condensation reactions, such as the Passerini and Ugi reactions, have become important synthetic approaches for high throughput combinatorial synthesis of small organic molecules. Many pharmaceutically important scaffolds can be constructed using these reactions. In spite of remarkable achievements of the two aforementioned reactions, their practice is still restrained by the malodor and the commercial availability of isocyanide reagents. Previous accounts of studies recently addressed this problem by immobilizing isocyanide functionality to solid supports; see (a) Zhang et al, Tetrahedron Lett., Vol. 37 (1996), pp. 751-754; (b) Short et al.,
Tetrahedron Lett.. Vol. 38 (1997), pp. 6653-6679; (c) Hulme et al, Tetrahedron Lett., Vol. 39 (1998), pp. 7227-7230. A variety of pharmaceutically important compounds, such as gamma- lactams, iminohydantoins, benzodiazepins, and diketopiperazines can be synthesized using resin bound isocyanides. The previous reported isocyanide resins have been prepared only from linear C3 to C14 amino acid attached and aniline-attached solid supports. The conversion of a-amino acid resins to corresponding isocyanide resins has not been reported, even though the starting resins are readily available from commercial sources.
SUMMARY OF THE INVENTION The subject invention involves a process for making isocyanide resin from amino acid resin comprising the following steps: (a) formylation of an amino acid resin of structure 1 to produce resin 2:
Figure imgf000003_0001
1 2 wherein R is selected from the group consisting of hydrogen, alkyl, aryl, and heterocyclyl;
(b) dehydration of resin 2 to produce isocycanide resin 3:
Figure imgf000003_0002
DETAILED DESCRIPTION OF THE INVENTION As used herein unless specified otherwise, "alkyl" means a hydrocarbon chain which is branched, linear or cyclic, saturated or unsaturated (but not aromatic), substituted or unsubstituted. The term "alkyl" may be used alone or as part of another word where it may be shortened to "alk" (e.g., in alkoxy, alkylacyl). Preferred linear alkyl have from one to about twenty carbon atoms, more preferably from one to about ten carbon atoms, more preferably still from one to about six carbon atoms, still more preferably from one to about four carbon atoms; most preferred are methyl or ethyl. Preferred cyclic and branched alkyl have from three to about twenty carbon atoms, more preferably from three to about ten carbon atoms, more preferably still from three to about seven carbon atoms, still more preferably from three to about five carbon atoms. Preferred cyclic alkyl have one hydrocarbon ring, but may have two, three, or more, fused or spirocycle hydrocarbon rings. Preferred alkyl are unsaturated with from one to about three double or triple bonds, preferably double bonds; more preferably they are mono-unsaturated with one double bond. Still more preferred alkyl are saturated. Saturated alkyl are referred to herein as "alkanyl". Alkyl unsaturated only with one or more double bonds (no triple bonds) are referred to herein as "alkenyl". Preferred substituents of alkyl include halo, alkyl, aryl, heterocyclyl, hydroxy, alkoxy, aryloxy, thio, alkylthio, arylthio, amino, alkylamino, arylamino, amide, alkylamide, arylamide, formyl, alkylacyl, arylacyl, carboxy and its alkyl and aryl esters and amides, nitro, and cyano. Also, unsubstituted alkyl are preferred.
As used herein, "heteroatom" means a nitrogen, oxygen, or sulfur atom. As used herein, "alkylene" means an alkyl which connects two other moieties, "heteroalkylene" means an alkylene having one or more heteroatoms in the connecting chain.
As used herein unless specified otherwise, "aryl" means an aromatic hydrocarbon ring (or fused rings) which is substituted or unsubstituted. The term "aryl" may be used alone or as part of another word (e.g., in aryloxy, arylacyl). Preferred aryl have from six to about fourteen, preferably to about ten, carbon atoms in the aromatic ring(s), and a total of from about six to about twenty, preferably to about twelve, carbon atoms. Preferred aryl is phenyl or naphthyl; most preferred is phenyl. Preferred substituents of aryl include halo, alkyl, aryl, heterocyclyl, hydroxy, alkoxy, aryloxy, thio, alkylthio, arylthio, amino, alkylamino, arylamino, amide, alkylamide, arylamide, formyl, alkylacyl, arylacyl, carboxy and its alkyl and aryl esters and amides, nitro, and cyano. Also, unsubstituted aryl are preferred.
As used herein unless specified otherwise, "heterocyclyl" means a saturated, unsaturated or aromatic cyclic hydrocarbon ring (or fused rings) with one or more heteroatoms in the hydrocarbon ring(s). Preferred heterocyclyls have from one to about six heteroatoms in the ring(s), more preferably one or two or three heteroatoms in the ring(s). Preferred heterocyclyls have from three to about fourteen, preferably to about ten, carbon plus heteroatoms in the ring(s), more preferably from three to about seven, more preferably still five or six, carbon plus heteroatoms in the rings(s); and a total of from three to about twenty carbon plus heteroatoms, more preferably from three to about ten, more preferably still five or six, carbon plus heteroatoms. Preferred heterocyclyls have one ring, but may have two, three, or more, fused or spirocycle rings. More preferred heterocyclyl rings include those which are one ring with 5 or 6 carbon plus heteroatoms in the ring with no more than three ring heteroatoms, no more than two of which are O and S. Still more preferred are such 5- or 6-ring atom heterocyclyls with one or two ring atoms being O or S and the others being C; or with one, two or three ring atoms being N and the others being C. Such preferred 5- or 6-ring atom heterocyclyls are preferably saturated, unsaturated with one or two double bonds, or aromatic. Such preferred 5- or 6-ring atom heterocyclyls are preferably a single ring; or fused with a 3- to 6-ring atom hydrocarbon ring which is saturated, unsaturated with one double bond, or aromatic (phenyl); or fused with another such 5- or 6-ring atom heterocyclic ring. Heterocyclyls are unsubstituted or substituted. Preferred heterocyclyl substituents are the same as for alkyl.
As used herein unless specified otherwise, "heteroaryl" means an aromatic heterocyclyl. The first step of the subject invention process for making isocyanide resin is the formylation of amino acid resin 1 as follows:
Figure imgf000005_0001
1 2
The formylating reagent is preferably formic acid in the presence of diisopropyl carbodiimide. The reaction is preferably carried out at a temperature of from about 0°C to about room temperature over a period of from about 1-4 hours.
Formylated resin 2 is dehydrated to isocyanide resin 3 using POClβ/diisopropylethylamine
(DIPEA) as follows:
Figure imgf000005_0002
The dehydration reaction is preferably carried out at a temperature of from about 0°C to about room temperature over a period of from about 3-8 hours.
The above process is generally quantitative and produces resins of light yellow color that are stable for months when stored refrigerated. Side chain protections typically used in the above processes, such as Boc, t-Bu, O-t-Bu, Tos, O-Bzl, and 2,2,4,6,7-pentamethyl-dihydrobenzofuran- sulfonyl (Pbf) are preserved during this conversion. The amino acid resin starting material is preferably a commercially-available α-amino acid resin. Non-limiting examples of commercially-available α-amino acid resins useful as starting materials for the subject process include Fmoc-Phe-Wang, Fmoc-Lys(Boc)-Wang, Fmoc-Tyr(tBu)- Wang, Fmoc-Asp(OtBu)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Arg(Pbf)-Merrifield, Boc-Phe- Merrifield, Boc-Ser(OBzl)-Merrifield, Boc-Met-Merrifield, Boc-His(Tos)-Merrifield, Boc- Thr(OBzl)-Merrifield, Boc-Ala-Merrifield resins.
In the above schemes, R is selected from hydrogen, alkyl, aryl, and heterocyclyl. Preferred R is unsubstituted or substituted alkyl, preferably having from 1 to about 8 carbon atoms, more preferably from 1 to about 4 carbon atoms. Preferred substituents of such alkyl include unsubstituted and substituted hydroxy, amino, thio, and phenyl. Preferred examples of R include tBu-OCOCH2-, tBu-OCOCH2CH2-, Pbf-NH(C=NH)NHCH2CH2CH2-, PhCH2-, PhCH2OCH2-,
CH SCH2CH2-, CH3_5 / fBuOPhCH2-, Boc-NHCH2CH2CH2CH2-. The following is a non-limiting example of the preparation of an isocyanide resin according to the subject invention.
A deprotected amino acid resin ester is swelled in anhydrous dichloromethane (DCM). Under the ice cooling, formic acid (8 eq) is added, followed by diisopropylcarbodiimide (DIC) (8 eq). The suspension is stirred at 0°C for half hour, then for 1 1/2 h at room temperature. The resin is washed and dried to a constant weight. The formylated amino acid resin is suspended in anhydrous CH2CI2. Under ice cooling and Argon protection, diisopropylethylamine (DIPEA) (15 eq) is cannulated, followed by POCI3 (5eq). The suspension is stirred at 0°C for 5 h, and then for 1 h at ambient room temperature. The resin is then washed with CH2CI2 in ether, then dried in a vacuum to a constant weight. The disappearance of formyl CO (-1740 cm"') and the emergence of NC (~ 2150 cm"') absorption in IR spectra confirms the conversion.
The isocyanide resins made according to the subject invention process are useful for making a variety of compounds which use an isocyanide reactant. Such compounds include, but are not limited to, dipeptides, γ-lactams, iminohydantoins, benzodiazepins, diketopiperazines. The isocyanide resins made according to the subject invention process are particularly useful for making combinatorial libraries of the above compounds.
The following scheme depicts a Ugi three component condensation (3CC) reaction using an isocyanide resin:
Figure imgf000006_0001
4
An aldehyde R2CHO (8 eq) is pre-mixed with a secondary amine RβRβ'NH (8 eq) in
CHCl /MeOH/trimethylorthoformate (TMOF) along with acetic acid. This solution is then agitated with an isocyanide resin 3 at about room temperature until the reaction is complete. The progress of the reaction can be followed by the disappearance of NC absorption in IR spectra. The reaction is generally complete in about 4 hours. The resin is washed, dried and treated with about 20% trifluoroacetic acid (TFA) in DCM to provide crude product after evaporating solvent. Purified product 4 is obtained using HPLC purification.
The subject resins are reliable isocyanide resources for Ugi 3CC reactions. The reactions on these resins tolerate a wide range of amines and aldehydes. Aliphatic aldehydes tend to provide products with higher yield and purity. Aromatic aldehydes, which are problematic in other Ugi condensation reactions, perform satisfactorily with these resins.
The following is a non-limiting example of a Ugi 3CC reaction. The aldehyde (8 eq), secondary amine (8 eq), and HOAc (4 eq) are mixed in CHClβ/MeOH/TMOF (1/1/1 , v/v/v) for 1 h. The mixture is then added to the isocyanide resin. The suspension is agitated at ambient temperature overnight. The resin is washed with MeOH, DMF, MeOH, CH2CI2, MeOH, then dried. If Wang resin is used, the product is released from the solid support by treating the resin with 20% TFA/CH2CI2 (2 x 20 min) at room temperature. If Merrifϊeld resin is used, the product is cyclizatively cleaved or released as a methyl amide using MeNH2/THF.
Non-limiting examples of compounds made according to the above scheme and example using corresponding aldehydes, secondary amines, and isocyanide resins include 3a - 3i:
Figure imgf000007_0001
3g 3h 3i While particular embodiments of the subject invention have been described, it will be obvious to those skilled in the arts that various changes and modifications of the subject invention can be made without departing from the spirit and scope of the invention. It is intended to cover, in the appended claims, all such modifications that are within the scope of this invention.

Claims

WHAT IS CLAIMED IS:
1. N process for making isocyanide resin from amino acid resin comprising the following steps:
(a) formylation of an amino acid resin of structure 1 to produce formylated resin 2:
Figure imgf000009_0001
1 2 characterized in that R is selected from the group consisting of hydrogen, alkyl, aryl, and heterocyclyl;
(b) dehydration of resin 2 to produce isocyanide resin 3:
Figure imgf000009_0002
2 3
2. The process of Claim 1 characterized in that step (b) is carried out with reagents comprising POCI3 and diisopropylethylamine.
3. The process according to any of the preceding claims characterized in that step (a) is carried out with reagents comprising formic acid and diisopropylcarbodiimide.
4. The process according to any of the preceding claims characterized in that step (b) is carried out at a temperature of from 0°C to room temperature over a period of from 3 to 8 hours.
5. The process according to any of the preceding claims characterized in that step (a) is carried out at temperature of 0°C to room temperature over a period of from 1 to 4 hours.
6. The process according to any of the preceding claims characterized in that step (b) is carried out at temperature of 0°C for 5 h, then at room temperature for 1 h.
7. The process according to any of the preceding claims characterized in that step (a) is carried out at a temperature of 0°C for Vi h, then at room temperature for 1 lΛ h.
8. The process according to any of the preceding claims characterized in that R is alkyl having from 1 to 8 carbon atoms, unsubstituted or substituted.
9. The process of Claim 8 characterized in that substituents of the alkyl R are selected from the group consisting of unsubstituted and substituted hydroxy, thio, amino, and phenyl.
10. Use of an isocyanide resin made according to any of the preceding claims in a Ugi three component condensation reaction.
PCT/US2001/004219 2000-02-09 2001-02-08 Process for making and using isocyanide resins WO2001058861A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001234975A AU2001234975A1 (en) 2000-02-09 2001-02-08 Process for making and using isocyanide resins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18126600P 2000-02-09 2000-02-09
US60/181,266 2000-02-09

Publications (1)

Publication Number Publication Date
WO2001058861A1 true WO2001058861A1 (en) 2001-08-16

Family

ID=22663545

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004219 WO2001058861A1 (en) 2000-02-09 2001-02-08 Process for making and using isocyanide resins

Country Status (2)

Country Link
AU (1) AU2001234975A1 (en)
WO (1) WO2001058861A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864051A (en) * 1988-09-02 1989-09-05 E. R. Squibb & Sons, Inc. Process for preparing 2-methoxyisobutylisonitrile
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864051A (en) * 1988-09-02 1989-09-05 E. R. Squibb & Sons, Inc. Process for preparing 2-methoxyisobutylisonitrile
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHENGZHI Z ET AL: "Synthesis of Tetrasubstituted Imidazoles via alpha-(N-acyl-N-alkylamino)-beta-ketoamides on Wang Resin", TETRAHEDRON LETTERS,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 37, no. 6, 5 February 1996 (1996-02-05), pages 751 - 754, XP004030252, ISSN: 0040-4039 *

Also Published As

Publication number Publication date
AU2001234975A1 (en) 2001-08-20

Similar Documents

Publication Publication Date Title
EP3266792A1 (en) Peptide synthesis method
Kolodziej et al. Solid-phase synthesis of 5, 6-dihydropyrimidine-2, 4-diones
Tamiaki et al. A novel protecting group for constructing combinatorial peptide libraries
Dressman et al. Solid phase synthesis of urea libraries using a diversifiable thiophenoxy carbonyl linker
US5101059A (en) Amino acid protecting groups
Kitagawa et al. Structural Analysis of. beta.-Turn Mimics Containing a Substituted 6-Aminocaproic Acid Linker
Oliva et al. Bicyclic pyrrolidine-isoxazoline γ amino acid: A constrained scaffold for stabilizing α-turn conformation in isolated peptides
Van Maarseveen Solid phase synthesis of heterocycles by cyclization/cleavage methodologies
Manesis et al. Synthesis of a novel class of peptides: dilactam-bridged tetrapeptides
CA2871328A1 (en) Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene by reaction of a disubstituted carbodiimide and dipropylene triamine
WO2001058861A1 (en) Process for making and using isocyanide resins
Reddy et al. A simple synthetic protocol for the protection of amides, lactams, ureas, and carbamates
Wu et al. Photoinduced Reaction of [60] Fullerene with Tertiary Amines: Synthesis of [60] Fulleropyrrolidines
US11692007B2 (en) Amino deprotection using 3-(diethylamino)propylamine
KR100645002B1 (en) METHOD FOR PRODUCING CYCLO-Asp-DPhe-NMeVal-Arg-Gly
Orelli et al. Selective monoformylation of 1, 3-diaminopropane derivatives
Valeur et al. PS-IIDQ: an efficient polymer-supported amide coupling reagent
KR100708581B1 (en) A process for the synthesis of ritonavir
Bhatt et al. Efficient one-pot HATU mediated coupling of dicarboxylic acid and amines for the synthesis of diamide at ambient temperature
Bellof et al. Soluble polymers in organic synthesis: 4. A new method for reversible attachment of C-terminal amino acids to poly (ethylene glycol) supports
WO2001055091A1 (en) Solid-supported process for making n-substituted peptide mimetic compounds
Lee Solid-Phase Syntheses of Nω-Propylarginine-Containing Dipeptides, Dipeptide Esters, and Dipeptide Amides
Yu et al. Structure based library approach to photosynthesis inhibitors: Combinatorial synthesis of hydrouracil library
Loubinoux et al. Protection of amines with the 4-azidomethylenoxybenzyloxycarbonyl group
JP2000516661A (en) Phosgenated oxime resin and method for producing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP